E. Barasch et al., PLASMA-FIBRINOGEN LEVELS AND THEIR CORRELATES IN 6457 CORONARY HEART-DISEASE PATIENTS - THE BEZAFIBRATE INFARCTION PREVENTION (BIP) STUDY, Journal of clinical epidemiology, 48(6), 1995, pp. 757-765
Citations number
31
Categorie Soggetti
Public, Environmental & Occupation Heath","Medicine, General & Internal
The association between fibrinogen measured in healthy individuals and
subsequent development of ischemic heart disease is well established,
but studies reporting fibrinogen levels in coronary heart disease pat
ients are scarce. Plasma fibrinogen was determined for 5729 men and 72
8 women (aged 45 to 74) with established coronary heart disease, scree
ned for participation in the Bezafibrate Infarction Prevention study,
with the following lipid profile at the time of the first screening vi
sit: total serum cholesterol less than or equal to 270 mg/dl, high den
sity lipoprotein cholesterol less than or equal to 45 mg/dl and trigly
ceride less than or equal to 300 mg/dl. Increased age was associated w
ith augmented plasma fibrinogen values. Age-adjusted fibrinogen levels
were higher in women than in men. A direct association was found betw
een mean fibrinogen levels and low density lipoprotein cholesterol. On
the other hand, the correlation with high density lipoprotein cholest
erol was inverse. Fibrinogen was also associated with body mass index,
behavioral variables and severity of coronary heart disease. In a mul
tivariable linear regression analysis performed, risk factors consider
ed explained merely 6 and 4% of fibrinogen variation for men and women
, respectively. Therefore, most of the fibrinogen level variability in
coronary heart disease patients is accounted for by factors that rema
in to be established by further research.